Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) has advised the syndicate of underwriters, led by Goldman Sachs, Morgan Stanley and UBS as joint global coordinators, on the initial public offering of Galderma Group AG (‘Galderma’) on the SIX Swiss Exchange. The IPO, which values Galderma at approximately CHF 15 billion (USD 17 billion), represents the largest IPO placement in Switzerland since 2017 and will likely to be one of the biggest in Europe this year.

The transaction, which is likely to raise CHF 2.3 billion (USD 2.6 billion), consisted of an issue of up to 46,839,534 registered shares (including over-allotment option), comprising the offer and sale of new and existing shares by Galderma and its selling shareholders (including affiliates / subsidiaries of EQT, GIC and ADIA).

Galderma is the pure-play dermatology category leader, delivering a portfolio of premium brands and services that span the full spectrum of dermatology.

The Freshfields team was led by partner Simone Bono (Frankfurt/London) and included senior associate Shruti Dusaj (London) and associates John Haviland (Frankfurt) and Ahmed Yacourt (London, all Capital Markets).

For further media inquiries, please contact Parissa Kerkhoff, Lead Germany & Austria Communications: T +49 211 49 79 230 | E parissa.kerkhoff@freshfields.com

About Freshfields Bruckhaus Deringer
Freshfields Bruckhaus Deringer is a global law firm. We have a long history of successfully assisting the world's leading industrial and financial companies, institutions and governments with their complex projects, transactions and challenges. Whether from our 29 offices in the world's major business and financial centres or with leading local law firms, our more than 2,800 lawyers provide comprehensive business law advice and combine their expertise to deliver decisive legal and industry solutions for our clients.